On October 20, JD Health and Pfizer reached a strategic cooperation. The two sides will jointly explore patient-centered and technology-driven integrated medical and health service models focusing on diseases such as obesity, diabetes, respiratory and anti-infection, skin diseases, migraines, and tumors. In the next phase of cooperation, the two sides will focus on Xianwei®, deepen ecological cooperation in the field of weight loss and metabolism, and promote long-term cooperation in channel collaboration and patient management.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.